|
|
| Oncologie > Etude de marché sectorielle |
| Cancer Therapeutics Markets |
|
|
|
|
€ 1 600,00 |
Editeur
: |
TriMark |
Langue
: |
Anglais |
Date de publication : |
Octobre 2003 |
Taille du document : |
173 |
Autres informations : |
Description , Table des matières |
| |
|
|
|
|
| |
Documents Publics |
1,200,000
documents |
Téléchargement illimités |
|
|
|
Etudes Privées |
50,000 rapports et études |
Paiement à la piéce |
|
|
|
|
| |
|
1.Télécharger nos rapports publics
Accés complet à plus de 1,2 Million de documents publics : études de marché, statistiques sectorielles, fiches pays, monographie d'entreprises, veille concurentielle, rapports annuels...
|
| Nos documents publics sur le même théme (5) |
|
|
|
| 162 pages | Septembre 2006 | Anglais
|
|
|
| Main
focus: |
cancer
|
| Research
focus: |
market definition,market outlook, |
| Geographic
focus: |
france,canada,finland,switzerland,norway,sweden,... |
| |
|
|
|
|
| 162 pages | Octobre 2006 | Anglais
|
|
|
| Main
focus: |
cancer
|
| Research
focus: |
market definition,market outlook, |
| Geographic
focus: |
france,canada,switzerland,finland,mauritius,usa,... |
| |
|
|
|
|
| 92 pages | Février 2008 | Anglais
|
|
|
| Main
focus: |
cancer,oncology,lymphoma,breast cancer,...,...
|
| Research
focus: |
market size and estimates,market definition, |
| Geographic
focus: |
usa,france,germany,united kingdom,switzerland,... |
| |
|
|
|
|
| 58 pages | Janvier 2005 | Anglais
|
|
|
| Main
focus: |
cancer,breast cancer,ovarian cancer,life insurance
|
| Research
focus: |
demand analysis,market size and estimates, |
| Geographic
focus: |
usa,canada,united kingdom |
| |
|
|
|
|
| 58 pages | Décembre 2005 | Anglais
|
|
|
| Main
focus: |
cancer,prostate cancer,oncology,cancer treatment,...,...
|
| Research
focus: |
market size and estimates,market outlook, |
| Geographic
focus: |
canada,usa,france,united kingdom,japan,germany,... |
| |
|
|
|
|
| Autres recherches sur le même thème |
|
|
|
| |
| |
|
| |
|
2.
Rechercher d'autres rapports et études à commander
Rechercher et commander ici parmi 50.000 études de marché publiées par les principaux instituts d'études internationaux
|
| Rapports privés en relation |
|
Stakeholder Opinions: Primary Brain Cancer - Temozolomide Turns Heads
144 pages | Juillet 2005 |
IntroductionThe incidence of glioblastoma is increasing.
Schering-Plough's temozolomide has gained approval as first line therapy for glioblastoma and has provided some survival benefit.
However |
3 040,00 €
|
| |
| |
Stakeholder Insight: Breast Cancer - Changing Treatment Paradigms for Local and Locally Advanced Breast Cancer
199 pages | Avril 2005 |
IntroductionAnthracycline-based regimens and tamoxifen are well-established in the treatment of early-stage breast cancer.
In recent days, however, agents such as Sanofi-Aventis's Taxotere and Astr |
9 120,00 €
|
| |
| |
The Eastern European Cancer Market Outlook to 2010
177 pages | Décembre 2005 |
The countries of the Eastern European region feature a range of diverse healthcare systems, but can be divided into two categories, those of the EU accession countries which feature the strongest pros |
2 443,75 €
|
| |
| |
Pipeline Insight: Hematological malignancies - Targeted treatments and immunotherapy infuse new blood
219 pages | Avril 2005 |
IntroductionGiven an enhanced understanding of the biological basis for oncogenesis and the benefit of immunotherapy approaches such as Genentech/Roche's Rituxan, it is no surprise that targeted treat |
9 120,00 €
|
| |
| |
Commercial Insight Top 20 Cancer Therapeutics
197 pages | Juillet 2006 |
IntroductionThe Top 20 cancer therapeutics generated sales of $20.1 billion in 2005 across the seven markets, set to reach $27.4 billion by 2015.
Cytotoxics currently constitute the majority, due t |
12 160,00 €
|
| |
| |
Commercial Insight: Antihormonal Therapies Aromatase Inhibitors Reinvigorate a Mature Market
122 pages | Juillet 2005 |
IntroductionThe antihormonal cancer therapy market is characterized by a mature nature and a relatively high level of saturation.
Despite this, growth will continue slowly at a CAGR of 0.9% during |
12 160,00 €
|
| |
| |
MarketWatch: Cancer
29 pages | Octobre 2005 |
Datamonitor's Cancer MarketWatch is a one-stop news shop for time-pressed executives.
It provides monthly insight into the key events in the cancer therapeutic area.
MarketWatch features all the |
170,00 €
|
| |
| |
Cancer Diagnostic Testing World Markets
245 pages | Janvier 2006 |
The purpose of this report is to describe the specific segment of the cancer diagnostics market called tumor marker testing.
It examines those clinical measurement devices, and their reagents and s |
2 800,00 €
|
| |
| |
Stakeholder Opinions: Chronic Leukemias - Curative Intent Raises the Bar
174 pages | Octobre 2005 |
IntroductionRecognizing that prolonging disease-free survival in chronic leukemia relies on the eradication of minimal residual disease has raised the bar for developers of novel pharmacotherapy.
I |
3 230,00 €
|
| |
| |
MarketWatch: Cancer
31 pages | Janvier 2005 |
Datamonitor's Cancer MarketWatch is a one-stop news shop for time-pressed executives.
It provides monthly insight into the key events in the cancer therapeutic area.
MarketWatch features all the |
160,00 €
|
| |
| |
|
| |
| Autres secteurs en relation |
|
|
|
| |
|
| |
| |
| Présentation de l'étude de marché - Description & Table des matières |
|
| Cancer Therapeutics Markets |
|
|
This report focuses on the efforts of biotechnology companies and pharmaceutical firms to incorporate new technologies for developing anti-cancer drugs into their corporate strategies. This report also examines cancer therapeutic products now on the market, as well as those currently under development that might be commercialized in the near future. Additionally, it profiles a number of firms that are actively involved in the marketing and developing of products to be used in the treatment of cancer-both large multinational corporations, such as Bristol-Myers Squibb, GlaxoSmithKline and Hoffmann-La Roche, and the smaller emerging biotechnology firms.
|
|
Table of content available on demand
|
|
|
PPLSEN
|
|
|
|
|
